Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Safety and Performance of the CathVision Cube® System

NCT05114382 is registered in ClinicalTrials.gov with CathVision ApS as lead sponsor.

NCT NCT05114382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05114382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Safety and Performance of the CathVision Cube® System
Lead sponsor
CathVision ApS
Phase
Not applicable
Overall status
Completed
Start date
October 2, 2020
Completion date
August 1, 2021
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrhythmia